Jeff Boyd

21.4k total citations · 4 hit papers
140 papers, 14.3k citations indexed

About

Jeff Boyd is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jeff Boyd has authored 140 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 52 papers in Genetics and 43 papers in Oncology. Recurrent topics in Jeff Boyd's work include Ovarian cancer diagnosis and treatment (43 papers), BRCA gene mutations in cancer (42 papers) and Genetic factors in colorectal cancer (29 papers). Jeff Boyd is often cited by papers focused on Ovarian cancer diagnosis and treatment (43 papers), BRCA gene mutations in cancer (42 papers) and Genetic factors in colorectal cancer (29 papers). Jeff Boyd collaborates with scholars based in United States, Canada and United Kingdom. Jeff Boyd's co-authors include Kenneth S. Korach, Douglas A. Levine, John I. Risinger, Hiroyuki Takahashi, Richard R. Barakat, Mark E. Robson, Graeme R. Frank, Bonny Specker, Dennis B. Lubahn and Timothy C. Williams and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jeff Boyd

138 papers receiving 13.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man

1994 1.8k citations Jeff Boyd, Hiroyuki Takahashi et al. New England Journal of Medicine profile →
Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation

2002 891 citations Noah D. Kauff, Jaya M. Satagopan et al. New England Journal of Medicine profile →
Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency

1997 866 citations Cesare Carani, Kenan Qin et al. New England Journal of Medicine profile →
Resistance to therapy caused by intragenic deletion in BRCA2

2008 754 citations Douglas A. Levine, Jeff Boyd et al. profile →

Peers

Countries citing papers authored by Jeff Boyd

Since Specialization

Citations

This map shows the geographic impact of Jeff Boyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Boyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Boyd more than expected).

Fields of papers citing papers by Jeff Boyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Boyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Boyd. The network helps show where Jeff Boyd may publish in the future.

Co-authorship network of co-authors of Jeff Boyd

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Boyd. A scholar is included among the top collaborators of Jeff Boyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Boyd. Jeff Boyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A New Role for ERα: Silencing via DNA Methylation of Basal, Stem Cell, and EMT Genes 2016 ·Molecular Cancer Research ·Eric A. Ariazi, John Taylor, Michael A. Black, Émmanuelle Nicolas, Michael Slifker, Diana J. Azzam, Jeff Boyd	26
2	Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome 2009 ·Clinical Cancer Research ·Andrew Berchuck, Edwin S. Iversen, Jingqin Luo, Jennifer Clarke, Hisani N. Horne, Douglas A. Levine, Jeff Boyd, Miguel A. Alonso, Angeles Alvarez Secord, Marcus Q. Bernardini, Jason C. Barnett, Todd Boren, Susan K. Murphy, Holly K. Dressman, Jeffrey R. Marks, Johnathan M. Lancaster	60
3	A Gene Signature Predicting for Survival in Suboptimally Debulked Patients with Ovarian Cancer 2008 ·Cancer Research ·Tomás Bonome, Douglas A. Levine, Joanna H. Shih, Mike Randonovich, Cindy A. Pise-Masison, Faina Bogomolniy, Laurent Ozbun, John Brady, J. Carl Barrett, Jeff Boyd, Michael J. Birrer	325
4	Unique Gene Expression Profile Based on Pathologic Response in Epithelial Ovarian Cancer 2005 ·Journal of Clinical Oncology ·Dimitrios Spentzos, Douglas A. Levine, (unknown), Hasan H. Otu, Jeff Boyd, Towia A. Libermann, Stephen A. Cannistra	109
5	Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer 2005 ·Clinical Cancer Research ·Kristin K. Zorn, Tomás Bonome, Lisa Gangi, Gadisetti V.R. Chandramouli, Christopher S. Awtrey, Ginger J. Gardner, J. Carl Barrett, Jeff Boyd, Michael J. Birrer	282
6	Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers 2005 ·Clinical Cancer Research ·Amir A. Jazaeri, Christopher S. Awtrey, Gadisetti V.R. Chandramouli, (unknown), Javed Khan, Christos Sotiriou, Olga Aprelikova, Cindy J. Yee, Kristin K. Zorn, Michael J. Birrer, J. Carl Barrett, Jeff Boyd	151
7	Pediatric radical abdominal trachelectomy for cervical clear cell carcinoma: A novel surgical approach 2005 ·Gynecologic Oncology ·Nadeem R. Abu‐Rustum, Wendy Su, Douglas A. Levine, Jeff Boyd, Yukio Sonoda, Michael P. LaQuaglia	36
8	Clinicopathologic Analysis of Early-stage Sporadic Ovarian Carcinoma 2004 ·The American Journal of Surgical Pathology ·Mario M. Leitão, Jeff Boyd, Amanda Hummer, Narciso Olvera, Crispinita D. Arroyo, Ennapadam Venkatraman, Rebecca N. Baergen, Don S. Dizon, Richard R. Barakat, Robert A. Soslow	50
9	Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation breakdown → 2002 ·New England Journal of Medicine ·Noah D. Kauff, Jaya M. Satagopan, Mark E. Robson, Lauren Scheuer, Martee L. Hensley, Clifford A. Hudis, Nathan A. Ellis, Jeff Boyd, Patrick I. Borgen, Richard R. Barakat, Larry Norton, Mercedes Castiel, Khédoudja Nafa, Kenneth Offit	891
10	Comparison of DNA- and RNA-Based Methods for Detection of TruncatingBRCA1 Mutations 2002 ·Human Mutation ·Irene L. Andrulis, Hoda Anton‐Culver, Jeanne C. Beck, Betsy Bove, Jeff Boyd, Saundra S. Buys, Andrew K. Godwin, John L. Hopper, Frederick W. B. Li, Susan L. Neuhausen, Hilmi Özçelik, David Peel, Regina M. Santella, Melissa C. Southey, Nathalie J. van Orsouw, Deon J. Venter, Jan Vijg, Alice S. Whittemore, (unknown)	58
11	Telomerase Activity in Sex Cord–Stromal Tumors of the Ovary 2001 ·Gynecologic Oncology ·Sean C. Dowdy, Dennis J. O’Kane, Gary L. Keeney, Jeff Boyd, Karl C. Podratz	5
12	Risk of Endometrial Carcinoma Associated with BRCA Mutation 2001 ·Gynecologic Oncology ·Douglas A. Levine, Oscar Lin, R.R. Barakat, Mark E. Robson, Deborah A. McDermott, (unknown), Jaya M. Satagopan, Kenneth Offit, Jeff Boyd	106
13	Carcinosarcoma of the Ovary in a Patient with a Germline BRCA2 Mutation: Evidence for Monoclonal Origin 2000 ·Gynecologic Oncology ·Yukio Sonoda, Patricia E. Saigo, Mark G. Federici, Jeff Boyd	37
14	Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome 1999 ·Breast Cancer Research and Treatment ·Jeff Boyd, Esther Rhei, Mark G. Federici, Patrick I. Borgen, Patrice Watson, Barbara Franklin, (unknown), Jane Lynch, Stephen J. Lemon, Henry T. Lynch	65
15	BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing 1998 ·American Journal of Obstetrics and Gynecology ·Stephen C. Rubin, M. Anne Blackwood, (unknown), Kian Behbakht, Ivor Benjamin, Timothy R. Rebbeck, Jeff Boyd	134
16	Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency breakdown → 1997 ·New England Journal of Medicine ·Cesare Carani, Kenan Qin, Manuela Simoni, Marco Faustini‐Fustini, (unknown), Jeff Boyd, Kenneth S. Korach, Evan R. Simpson	866
17	Hereditary Ovarian Cancer: Molecular Genetics and Clinical Implications 1997 ·Gynecologic Oncology ·Jeff Boyd, Stephen C. Rubin	87
18	Expression and mutational analysis of P53 in stage IB and IIA cervical cancers 1996 ·American Journal of Obstetrics and Gynecology ·Ivor Benjamin, Patricia E. Saigo, Connie L. Finstad, Hiroyuki Takahashi, (unknown), Stephen C. Rubin, Jeff Boyd	17
19	Aflatoxin B₁-induced immortalization of cultured skin fibroblasts from a patient with Li-Fraumeni syndrome 1995 ·Carcinogenesis ·Takeki Tsutsui, Takafumi Fujino, Seiji Kodama, Michael A. Tainsky, Jeff Boyd, J. Carl Barrett	23
20	Characterization of murine cell lines from Diethylstilbestrol-Induced uterine endometrial Adenocarcinomas 1992 ·In Vitro Cellular & Developmental Biology - Animal ·Charles Hébert, (unknown), Kenneth S. Korach, Jeff Boyd, J. Carl Barrett, John A. McLachlan, Retha R. Newbold	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact